MNKD
MannKind Corporation (MNKD)
$85
About MannKind Corporation (MNKD)
MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.
Details
Daily high
$7.07
Daily low
$6.30
Price at open
$6.34
52 Week High
$7.63
52 Week Low
$3.17
Market cap
1.9B
Dividend yield
0.00%
Volume
7.2M
Avg. volume
3.3M
P/E ratio
97.44
MannKind Corporation News
Details
Daily high
$7.07
Daily low
$6.30
Price at open
$6.34
52 Week High
$7.63
52 Week Low
$3.17
Market cap
1.9B
Dividend yield
0.00%
Volume
7.2M
Avg. volume
3.3M
P/E ratio
97.44